Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD

4:00 AM MDT | July 1, 2008 |

Alex Scott

Contract fine chemicals firm Lonza (Basel, Switzerland) says it has secured a deal with biotech firm Osiris Therapeutics (Columbia, MD) to manufacture what could be the world’s first stem cell drug. Lonza will build a new manufacturing facility at its...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

Searchable online archive access of the last 2 years of Chemical Week.
Print or digital magazine subscription
Price and market change alerts
Economic data and statistics
Buyers' Guides
Webcasts | whitepapers

search

in this issue

premium

events

free features

advertising

customer care

Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

Connect with IHS Chemical Week

Quick links

Our related sites

search

in this issue

premium

events

free features

advertising

customer care

Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD

Forgot your user ID or password? Click here to have it sent to you.

Not an IHS Chemical Week 24/7 member yet?

Here's why you should be:

Connect with IHS Chemical Week

Quick links

Our related sites

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?